Endoluminal Therapy for Barrett's Esophagus

Herbert C. Wolfsen

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

This article reviews methods to minimize the complications associated with endoscopic therapy for patients with Barrett's esophagus. To place this discussion in context, the natural history of Barrett's esophagus and the risks associated with progression to dysplasia and invasive carcinoma are reviewed. Operative esophageal resection traditionally is recommended for patients with Barrett's high-grade dysplasia and early carcinoma, and these surgical risks also are reviewed. Finally, all currently approved and commercially available methods for endoscopic ablation and resection of Barrett's disease are categorized according to their application methods of ablation: focal ablation, field ablation, and mucosal resection. The clinical experience with these devices is reviewed with their associated adverse events and complications. Caveats, concerns, and recommendations are discussed to help minimize the complications associated with the use of these important technologies that hold the promise of removing or destroying Barrett's disease to prevent the development of invasive carcinoma.

Original languageEnglish (US)
Pages (from-to)59-82
Number of pages24
JournalGastrointestinal Endoscopy Clinics of North America
Volume17
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Barrett Esophagus
Carcinoma
Therapeutics
Technology
Equipment and Supplies

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Cite this

Endoluminal Therapy for Barrett's Esophagus. / Wolfsen, Herbert C.

In: Gastrointestinal Endoscopy Clinics of North America, Vol. 17, No. 1, 01.2007, p. 59-82.

Research output: Contribution to journalArticle

Wolfsen, Herbert C. / Endoluminal Therapy for Barrett's Esophagus. In: Gastrointestinal Endoscopy Clinics of North America. 2007 ; Vol. 17, No. 1. pp. 59-82.
@article{76a618f9b42e4a14aa4161442f751b43,
title = "Endoluminal Therapy for Barrett's Esophagus",
abstract = "This article reviews methods to minimize the complications associated with endoscopic therapy for patients with Barrett's esophagus. To place this discussion in context, the natural history of Barrett's esophagus and the risks associated with progression to dysplasia and invasive carcinoma are reviewed. Operative esophageal resection traditionally is recommended for patients with Barrett's high-grade dysplasia and early carcinoma, and these surgical risks also are reviewed. Finally, all currently approved and commercially available methods for endoscopic ablation and resection of Barrett's disease are categorized according to their application methods of ablation: focal ablation, field ablation, and mucosal resection. The clinical experience with these devices is reviewed with their associated adverse events and complications. Caveats, concerns, and recommendations are discussed to help minimize the complications associated with the use of these important technologies that hold the promise of removing or destroying Barrett's disease to prevent the development of invasive carcinoma.",
author = "Wolfsen, {Herbert C.}",
year = "2007",
month = "1",
doi = "10.1016/j.giec.2006.12.003",
language = "English (US)",
volume = "17",
pages = "59--82",
journal = "Gastrointestinal Endoscopy Clinics of North America",
issn = "1052-5157",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Endoluminal Therapy for Barrett's Esophagus

AU - Wolfsen, Herbert C.

PY - 2007/1

Y1 - 2007/1

N2 - This article reviews methods to minimize the complications associated with endoscopic therapy for patients with Barrett's esophagus. To place this discussion in context, the natural history of Barrett's esophagus and the risks associated with progression to dysplasia and invasive carcinoma are reviewed. Operative esophageal resection traditionally is recommended for patients with Barrett's high-grade dysplasia and early carcinoma, and these surgical risks also are reviewed. Finally, all currently approved and commercially available methods for endoscopic ablation and resection of Barrett's disease are categorized according to their application methods of ablation: focal ablation, field ablation, and mucosal resection. The clinical experience with these devices is reviewed with their associated adverse events and complications. Caveats, concerns, and recommendations are discussed to help minimize the complications associated with the use of these important technologies that hold the promise of removing or destroying Barrett's disease to prevent the development of invasive carcinoma.

AB - This article reviews methods to minimize the complications associated with endoscopic therapy for patients with Barrett's esophagus. To place this discussion in context, the natural history of Barrett's esophagus and the risks associated with progression to dysplasia and invasive carcinoma are reviewed. Operative esophageal resection traditionally is recommended for patients with Barrett's high-grade dysplasia and early carcinoma, and these surgical risks also are reviewed. Finally, all currently approved and commercially available methods for endoscopic ablation and resection of Barrett's disease are categorized according to their application methods of ablation: focal ablation, field ablation, and mucosal resection. The clinical experience with these devices is reviewed with their associated adverse events and complications. Caveats, concerns, and recommendations are discussed to help minimize the complications associated with the use of these important technologies that hold the promise of removing or destroying Barrett's disease to prevent the development of invasive carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=33947596622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947596622&partnerID=8YFLogxK

U2 - 10.1016/j.giec.2006.12.003

DO - 10.1016/j.giec.2006.12.003

M3 - Article

C2 - 17397777

AN - SCOPUS:33947596622

VL - 17

SP - 59

EP - 82

JO - Gastrointestinal Endoscopy Clinics of North America

JF - Gastrointestinal Endoscopy Clinics of North America

SN - 1052-5157

IS - 1

ER -